Human Multipotent Adult Progenitor Cells Effectively Reduce GVHD While Preserving Graft-Versus-Leukemia Activity after Allogeneic BMT

被引：0
|
作者：
Metheny, Leland [1 ]
机构：
[1] Univ Hosp Cleveland, Cleveland, OH 44106 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2014年 / 14卷
关键词：
D O I：
10.1016/j.clml.2014.06.104
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
906
引用
收藏
页码：S158 / S158
页数：1
相关论文
共 50 条
  • [21] Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process
    Chen, BJ
    Cui, XY
    Liu, CX
    Chao, NJ
    BLOOD, 2002, 99 (09) : 3083 - 3088
  • [22] Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia
    L Weiss
    A Abdul-Hai
    R Or
    G Amir
    A Polliack
    Bone Marrow Transplantation, 2003, 31 : 11 - 15
  • [23] Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia
    Weiss, L
    Abdul-Hai, A
    Or, R
    Amir, G
    Polliack, A
    BONE MARROW TRANSPLANTATION, 2003, 31 (01) : 11 - 15
  • [24] Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
    Giralt, S
    Estey, E
    Albitar, M
    vanBesien, K
    Rondon, G
    Anderlini, P
    OBrien, S
    Khouri, I
    Gajewski, J
    Mehra, R
    Claxton, D
    Andersson, B
    Beran, M
    Przepiorka, D
    Koller, C
    Kornblau, S
    Korbling, M
    Keating, M
    Kantarjian, H
    Champlin, R
    BLOOD, 1997, 89 (12) : 4531 - 4536
  • [25] Macrophage Inflammatory Protein-2/CXCR2 Blockade Attenuates Acute Graft-versus-Host Disease while Preserving Graft-versus-Leukemia Activity
    Park, Minhwa
    Cho, Kyung-Ah
    Woo, So-Youn
    Ryu, Kyung-Ha
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [26] Human Mesenchymal Stem Cells Attenuate Graft-Versus-Host Disease and Maintain Graft-Versus-Leukemia in Murine Allogeneic Bone Marrow Transplantation
    Auletta, Jeffery J.
    Eid, Saada
    Keller, Matthew
    Metheny, Leland
    Guardia-Wolff, Rocio
    Lee, Zhenghong
    Solchaga, Luis A.
    Cooke, Kenneth R.
    BLOOD, 2011, 118 (21) : 831 - 832
  • [27] Use of unrelated marrow grafts compensates for reduced graft-versus-leukemia reactivity after T-cell depleted allogeneic BMT for chronic myelogenous leukemia.
    Hessner, M
    Endean, D
    Casper, J
    Horowitz, M
    Taylor, C
    Roth, M
    Flomenberg, N
    Drobyski, W
    BLOOD, 1995, 86 (10) : 1143 - 1143
  • [28] Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
    Janikashvili, Nona
    Gerard, Claire
    Thebault, Marine
    Brazdova, Andrea
    Boibessot, Clovis
    Cladiere, Claudie
    Ciudad, Marion
    Greigert, Helene
    Ouandji, Sethi
    Ghesquiere, Thibault
    Samson, Maxime
    Audia, Sylvain
    Saas, Philippe
    Bonnotte, Bernard
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [29] Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation
    Cao, Jiang
    Chen, Chong
    Zeng, Lingyu
    Li, Li
    Li, Zhenyu
    Xu, Kailin
    LEUKEMIA RESEARCH, 2010, 34 (10) : 1374 - 1382
  • [30] Graft-versus-leukemia activity after T-cell depletion and cytokine activation of murine allogeneic MHC-identical peripheral blood progenitor grafts.
    Glass, B
    Uharek, L
    Zeis, M
    Steinmann, J
    Dreger, P
    Gassmann, W
    Loffler, H
    Schmitz, N
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 618 - 618
12345